Bremelanotide PT-141

An FDA-approved medication (Vyleesi) for low sexual desire in women, also studied off-label for erectile dysfunction. Human trials back up modest improvements in sexual desire, though nausea and a temporary rise in blood pressure are common side effects.

Also known as PT-141, Vyleesi, Bremelanotida, 6Y24O4F92S, PT 141, Bremelanotidum, RefChem:58355, Bremelanotide [USAN:INN], Vyleesi (TN)

Effects Libido

Routes Nasal Subcutaneous

Legal status Prescription drug

WADA Not listed

Molecular Structure of C₅₀H₆₈N₁₄O₁₀

Drag to rotate · scroll to zoom

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula: C50H68N14O10
Molar mass: 1025.2
CAS: 189691-06-3
PubChem CID: 9941379
IUPAC name: (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid
InChIKey: FFHBJDQSGDNCIV-MFVUMRCOSA-N